Cargando…

Medication use for the treatment of diabetes in obese individuals

Obesity is a major cause of type 2 diabetes and may complicate type 1 diabetes. Weight loss for obese individuals with diabetes has many health benefits, often leads to improvement in glucose control and sometimes, in type 2 diabetes, near normalisation of abnormal glucose metabolism. Weight loss is...

Descripción completa

Detalles Bibliográficos
Autor principal:	Wilding, John P. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448959/ https://www.ncbi.nlm.nih.gov/pubmed/28501906 http://dx.doi.org/10.1007/s00125-017-4288-1

Ejemplares similares

Beyond lifestyle interventions: exploring the potential of anti‐obesity medications in the UK
por: Wilding, J. P. H.
Publicado: (2018)

Metabolic surgery for the treatment of type 2 diabetes in obese individuals
por: Cummings, David E., et al.
Publicado: (2017)

Night eating syndrome: implications for severe obesity
por: Cleator, J, et al.
Publicado: (2012)

Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review
por: Williams, Scott M., et al.
Publicado: (2019)

Anti-obesity drugs: past, present and future
por: Rodgers, R. John, et al.
Publicado: (2012)

Patients’ Perspectives of Oral and Injectable Type 2 Diabetes Medicines, Their Body Weight and Medicine-Taking Behavior in the UK: A Systematic Review and Meta-Ethnography
por: Psarou, Aikaterini, et al.
Publicado: (2018)

Medications for the treatment of obesity in adolescents
por: Woodard, Kaylee, et al.
Publicado: (2020)

Advantages of bariatric medicine for individualized prevention and treatments: multidisciplinary approach in body culture and prevention of obesity and diabetes
por: Dimitrov, Dimiter V., et al.
Publicado: (2011)

Adipocytes in obesity: A perfect reservoir for SARS-CoV-2?
por: Zhu, JingJing, et al.
Publicado: (2023)

Diets and Recipes and the Treatment of Diabetes and Obesity
Publicado: (1937)

Empowerment in the Treatment of Diabetes and Obesity
por: Łuczyński, Włodzimierz, et al.
Publicado: (2016)

The Role of Obesity and Diabetes in Dementia
por: Selman, Ashley, et al.
Publicado: (2022)

Individualizing medical treatment of overactive bladder
por: Kuo, Hann-Chorng
Publicado: (2018)

The Role of Anti-Obesity Medication in Prevention of Diabetes and Its Complications
por: Oh, Tae Jung
Publicado: (2019)

Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?
por: Eckel, Robert H., et al.
Publicado: (2011)

The importance of weight management in type 2 diabetes mellitus
por: Wilding, J P H
Publicado: (2014)

Obesity-Associated Non-T2 Mechanisms in Obese Asthmatic Individuals
por: Shailesh, Harshita, et al.
Publicado: (2023)

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
por: Budoff, Matthew J., et al.
Publicado: (2017)

Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes
por: Sullivan, Shelby
Publicado: (2017)

Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
por: Isidro, Maria Luisa, et al.
Publicado: (2010)

SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials
por: Harman, Nicola L., et al.
Publicado: (2017)

Getting ‘Smad' about obesity and diabetes
por: Tan, C K, et al.
Publicado: (2012)

The Peripheral Neuropathy Prevalence and Characteristics Are Comparable in People with Obesity and Long-Duration Type 1 Diabetes
por: Lim, J. Z. M., et al.
Publicado: (2022)

Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review
por: Deng, You, et al.
Publicado: (2022)

Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals
por: Mercer, Emileigh, et al.
Publicado: (2012)

Efficacy of Postprandial Exercise in Mitigating Glycemic Responses in Overweight Individuals and Individuals with Obesity and Type 2 Diabetes—A Systematic Review and Meta-Analysis
por: Kang, Jie, et al.
Publicado: (2023)

Medical Devices in Obesity Treatment
por: Ruban, Aruchuna, et al.
Publicado: (2019)

Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals
por: Ahmad, Aftab, et al.
Publicado: (2019)

Prevalence and determinants of obesity among individuals with diabetes in Indonesia
por: Azam, Mahalul, et al.
Publicado: (2023)

The thermoregulation of healthy individuals, overweight–obese, and diabetic from the plantar skin thermogram: a clue to predict the diabetic foot
por: Renero-C, Francisco-J
Publicado: (2017)

COVID-19 and liver injury in individuals with obesity
por: Lempesis, Ioannis G, et al.
Publicado: (2023)

Obesity pillars roundtable: Obesity and individuals from the Mediterranean region and Middle East
por: Bays, Harold Edward, et al.
Publicado: (2022)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander, Priscilla A
Publicado: (2012)

Optimal Pharmacologic Treatment Strategies in Obesity and Type 2 Diabetes
por: Goswami, Gayotri, et al.
Publicado: (2014)

Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
por: Seo, Young-Gyun
Publicado: (2021)

Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy
por: Richard, Caroline, et al.
Publicado: (2017)

Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats
por: Sridhar, Ananyaa, et al.
Publicado: (2022)

Cracking the combination: Gut hormones for the treatment of obesity and diabetes
por: Alexiadou, Kleopatra, et al.
Publicado: (2019)

The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial
por: Sargeant, Jack A., et al.
Publicado: (2022)

The UPS in diabetes and obesity
por: Wing, Simon S
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_13q1f0nc4r58ih426phnhp9gc7